" class="no-js "lang="en-US"> Juno Medical - Medtech Alert
Monday, October 20, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Juno Medical | Pharmtech Focus

Juno Medical

About Juno Medical

Juno Medical

Convenient, affordable care designed for the whole family.

Juno is changing how healthcare works.

We’ve created a one-stop solution for you and your family’s day-to-day care needs that features exceptional hospitality, modern technology, and transparent prices that won’t break the bank.

Related Story

Fundraising

 Juno Medical Raises $5.4M in Seed Financing to Reimagine Primary Care for the 99% | Pharmtech Focus

Juno Medical Raises $5.4M in Seed Financing to Reimagine Primary Care for the 99%

August 2 2021

Juno Medical, the modern doctor’s office that’s designed for the 99%, today announces $5.4 million in seed […]